On March 3-5, Karolina Strzebońska attended the ESMO Targeted Anticancer Therapies Congress 2025 in Paris. She presented poster entitled „Risk and benefit for targeted therapy and immunotherapy agents in basket trials in oncology: a systematic review with meta-analysis”.